TOMI Partnership with AV8R Solutions Targets Airports and Premier Private Aviation Service Providers
TOMI Environmental Solutions (NASDAQ:TOMZ) announced advancements in its partnership with AV8R Solutions, focusing on the aviation industry. Since December 2020, AV8R has purchased five SteraMist Environment Systems to provide disinfection services to commercial airports and private aviation facilities. Projected growth includes further expansion into the restoration and remediation sectors through a partnership with RestorePro. This cross-sector collaboration is expected to significantly increase the consumption of TOMI’s Binary Ionization Technology (BIT) solution, requiring additional environmental systems by year's end.
- AV8R Solutions purchased five SteraMist Environment Systems to enhance disinfection services in aviation and commercial sectors.
- Expansion into restoration and remediation fields is projected to boost demand for TOMI's BIT solution.
- None.
BEVERLY HILLS, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ:TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products, provided an update on its partnership with AV8R Solutions, a SteraMist service provider and manufacturing representative with focus on aviation industry.
In December 2020, AV8R purchased two SteraMist Environment Systems and began servicing aviation, hospitals, commercial and government facilities while promoting and selling SteraMist within the commercial industry. In March 2021, AV8R purchased an additional three Environment Systems to assist with their growing service business. TOMI is working closely with AV8R to expand SteraMist throughout the air transportation industry to disinfect commercial airport terminals, fixed based operators (FBOs), commercial airlines and private jets.
AV8R Solutions is working with commercial airports and FBOs in the Northeast that provide premier private aviation services including aircraft terminal services, aircraft ground handling services, fueling and line services, concierge, ground transportation, catering, hangar, and upscale private charter. AV8R is projected to service several airports and FBOs 2Q2021 as they further expand into aviation and the commercial division.
With a second mission to partner with insurance companies, service will further be expanded into the restoration and remediation industry. AV8R has currently partnered with RestorePro™ of New Jersey and Pennsylvania. RestorePro has already begun using SteraMist on several large commercial and residential projects with great success. This cross-sector expansion will significantly increase the consumption of BIT solution and will require the deployment of a minimum of three additional environmental systems by year end.
Retired USAF Colonel and CEO of AV8R, Jeff Stout commented, “We selected SteraMist over other available products based on safety of aircraft and customers, efficacy, product quality and TOMI's reputation in the industry, and are pleased with our partnership.”
TOMI’s Vice President of Commercial and Business Development, Gary Zamieroski states, “SteraMist is the perfect disinfection treatment for aviation because the organic ionized Hydrogen Peroxide (iHP) technology produces no toxic byproducts while protecting the aircraft and materials along with all passengers and crew onboard. Our partnership with AV8R Solutions provides a strategic opportunity to further grow SteraMist into the commercial and private aircraft industry.”
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.
TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.
TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.
For additional information, please visit http://www.tomimist.com/ or contact us at info@tomimist.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,” “projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.
INVESTOR RELATIONS CONTACT
John Nesbett/Jennifer Belodeau
IMS Investor Relations
jnesbett@imsinvestorrelations.com
203-972-9200
